WAM
EW icon

Worth Asset Management’s Edwards Lifesciences EW Stock Holding History

Worth Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-45
Closed -$4.25K – 193
2023
Q2 		$4.25K Hold
45
– – ﹤0.01% 372
2023
Q1 		$3.72K Hold
45
– – ﹤0.01% 396
2022
Q4 		$3.36K Hold
45
– – ﹤0.01% 391
2022
Q3 		$4K Sell
45
-84
-65% -$8.08K ﹤0.01% 363
2022
Q2 		$12K Sell
129
-6
-4% -$621 0.01% 335
2022
Q1 		$13K Buy
+135
New +$15.1K 0.01% 337

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Worth Asset Management's EW Position: Q3 2023 in Review

Worth Asset Management sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 45 shares — an estimated $4.25K sold.

Worth Asset Management first reported a position in EW in Q1 2022 and held it in 6 quarters. The position peaked at $13K in Q1 2022. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

  • Worth Asset Management reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
  • Worth Asset Management sold 45 Edwards Lifesciences shares in Q3 2023, an estimated $4.25K.
  • Worth Asset Management first reported a position in Edwards Lifesciences in Q1 2022 and held it in 6 quarters.
  • Worth Asset Management's Edwards Lifesciences position peaked at $13K in Q1 2022.
  • 1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Worth Asset Management's 13F filing for Q3 2023, filed 11 Oct 2023.